THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT

Despite the rather high efficiency of treatment for epilepsy (overall, 65–70 % of patients can achieve remission or show a considerable decrease in the frequency of seizures), there remains a challenge due to the need to use antiepileptic drugs long and regularly: therapy adherence, compliance, trea...

Full description

Bibliographic Details

Published in:	Русский журнал детской неврологии
Main Authors:	K. Yu. Mukhin, O. A. Pylaeva, M. Yu. Bobylova
Format:	Article
Language:	Russian
Published:	ABV-press 2016-08-01
Subjects:	epilepsy antiepileptic drug brand-name drug generic drug bioequivalence efficiency of treatment tolerability of treatment
Online Access:	https://rjdn.abvpress.ru/jour/article/view/152